Diaphragm movement and breathing drive in people with OSA, COPD, or both
Official title: Diaphragmatic Morphofunction and Respiratory Drive in OSA and COPD: Insights From Ultrasound and EMG-based Cross-Sectional Analysis
Run by Nanjing Medical University · NCT07003399 · Data updated 2026-11-12
Using ultrasound and surface diaphragm EMG, this cross-sectional study will see if diaphragm movement and breathing drive differ between people with OSA, COPD, both conditions, and healthy adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | August 31, 2025 |
| Study ends | August 31, 2025 |
| Registry record updated | June 25, 2025 |
| Trial ID | NCT07003399 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 who can give informed consent and who have OSA (AHI ≥ 5), COPD per GOLD criteria, both conditions (overlap), or are healthy volunteers without respiratory or sleep disorders are ideal candidates.
✕Probably not a fit
People with severe cardiovascular, hepatic, or renal disease, neuromuscular disorders affecting respiratory muscles, recent upper airway or thoracic surgery, pregnant or breastfeeding women, or those unable to complete testing are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, cross-sectional study compares diaphragmatic structure and respiratory drive across four groups: OSA, COPD, overlap syndrome, and healthy controls. Participants will undergo overnight polysomnography, spirometry, impulse oscillometry, diaphragm ultrasound, and surface diaphragm EMG to measure thickness, excursion, thickening fraction, and EMGdi parameters (rest, max, %max). Investigators will compare group differences and examine relationships between diaphragmatic indicators and respiratory measures such as FEV1, FVC, AHI, and R5-R20. The aim is to identify objective diaphragmatic markers that could characterize dysfunction and help differentiate overlap syndrome.
Why it matters
Potential benefit: If successful, the findings could provide objective diaphragmatic markers to help distinguish overlap syndrome from OSA or COPD and support more targeted clinical assessment.
How similar studies have gone: Previous work using diaphragm ultrasound and EMG in COPD and some OSA cohorts has shown promising but limited results, while targeted assessment of overlap syndrome remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients aged between 18 and 80 years. 2. For OSA Group: Diagnosed obstructive sleep apnea with AHI ≥ 5 events/hour based on overnight polysomnography. 3. For COPD Group: Diagnosed chronic obstructive pulmonary disease based on GOLD guidelines. 4. For Overlap Group: Diagnosed both OSA (AHI ≥ 5) and COPD. 5. For Control Group: Healthy volunteers with no known respiratory diseases or sleep disorders. 6. Ability and willingness to provide informed consent for participation in the study. Exclusion Criteria: 1. Severe cardiovascular diseases (e.g., unstable angina, heart failure NYHA III/IV). 2. Severe hepatic or renal insufficiency. 3. Neuromuscular diseases affecting respiratory muscles. 4. Recent upper airway or thoracic surgery (within 3 months). 5. Pregnancy or breastfeeding. 6. Participants who cannot complete assessments due to cognitive impairment or poor cooperation.
Where it's running
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Ding Ning, doctor
- Email: dr.ningding@live.cn
- Phone: 86-25-68136723
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.